347396-82-1
347396-82-1
Chemical Structure
Ranibizumab (anti-VEGF)
Synonym(s): RG-6321 (anti-VEGF)
- CAS No.: 347396-82-1
- Formula:N/A
- Molecular Weight:(49.19 kDa)
IUPAC Name: 4,5-dichloro-1H-indazol-3-amine
SMILES: [Ranibizumab (anti-VEGF)]
Biological Activity: Ranibizumab (RG-6321) (anti-VEGF) is a humanized anti-VEGF monoclonal antibody fragment and can recognize all VEGF-A isoforms (VEGF110, VEGF121, and VEGF165)[1]. Ranibizumab (anti-VEGF) slows vision loss in vivo and is used for wet age-related macular degeneration (AMD) research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ranibizumab (anti-VEGF) | 99.60% | Ranibizumab (RG-6321) (anti-VEGF) is a humanized anti-VEGF monoclonal antibody fragment and can recognize all VEGF-A isoforms (VEGF110, VEGF121, and VEGF165). Ranibizumab (anti-VEGF) slows vision loss in vivo and is used for wet age-related macular degeneration (AMD) research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
